紫外線B波照射による皮膚障害とその予防・治療 : γ-Tocopherol誘導体塗布の効果  [in Japanese] UVB-induced Skin Damage and the Protection/Treatment : Effects of a Novel, Hydrophilic γ-Tocopherol Derivative  [in Japanese]

    • 小林 静子 KOBAYASHI Shizuko
    • 共立薬科大学分子生理学 Molecular Physiology, Kyoritsu University of Pharmacology:(Present address)Kyontsu University of Pharmacology

Abstract

Ultraviolet radiation is the major environmental cause of skin damage. Although only 0.5% of ultraviolet B (UVB) radiation reaches the earth, it is the main cause of sunburn and inflammation and the most carcinogenic constituent of sunlight. We investigated whether the topical application of a novel, water-soluble γ-tocopherol (γ-Toc) derivative, γ-tocopherol-N,N-dimethylgrycinate hydrochloride (γ-TDMG), could protect against UV-induced skin damage. Topical pre- or postapplication of γ-TDMG solution significantly prevented sunburn cell formation, lipid peroxidation, and edema/inflammation that were induced by exposure to a single dose of UV irradiation. Cyclooxygenase-2 (COX-2)-catalyzed synthesis of prostaglandin E_2 (PGE_2) levels seen after UV exposure were significantly suppressed by pre- or posttreatment with γ-TDMG. The increase in COX-2 activity was significantly inhibited by γ-TDMG, suggesting that the reduction in PGE_2 concentration was due to the direct inhibition of COX-2 activity by γ-TDMG. The derivative strongly inhibited inducible nitric oxide synthase mRNA expression and nitric oxide production. With the application of γ-TDMG, the pigmentation in melanocytes was lightened and the increase melanin concentration was suppressed, γ-TDMG is converted to γ-Toc in the skin and has higher bioavailability than γ-Toc itself. These results suggest that γ-TDMG-derived γ-Toc acts as an antioxidant, antiinflammatory and antipigmentation agent. Our data further suggest that the topical application of γ-TDMG may be efficacious in preventing and reducing UV-induced skin damage in humans.

Journal

Journal of the Pharmaceutical Society of Japan   [List of Volumes]

Journal of the Pharmaceutical Society of Japan 126(9), 677-693, 2006-09-01  [Table of Contents]

The Pharmaceutical Society of Japan

References:  41

You must have a user ID to see the references.If you already have a user ID, please click "Login" to access the info.New users can click "Sign Up" to register for an user ID.

Cited by:  3

You must have a user ID to see the cited references.If you already have a user ID, please click "Login" to access the info.New users can click "Sign Up" to register for an user ID.

Preview

Preview

Codes

  • NII Article ID (NAID) :
    110006154980
  • NII NACSIS-CAT ID (NCID) :
    AN00284903
  • Text Lang :
    JPN
  • Article Type :
    Journal Article
  • ISSN :
    00316903
  • NDL Article ID :
    8084103
  • NDL Source Classification :
    ZS51(科学技術--薬学)
  • NDL Call No. :
    Z19-411
  • Databases :
    CJP  CJPref  NDL  NII-ELS  J-STAGE 

Export